Letters to the Editor - page 5

Assessing sex differences in patients with takotsubo syndrome requires homogeneous cohorts. Authors' reply

Monika Budnik, Grzegorz Opolski

Pol Arch Intern Med. 2020, Vol. 130, No. 1: 88-88 / DOI: 10.20452/pamw.15168

Assessing sex differences in patients with takotsubo syndrome requires homogeneous cohorts

Josef Finsterer, Claudia Stöllberger

Pol Arch Intern Med. 2020, Vol. 130, No. 1: 87-88 / DOI: 10.20452/pamw.15167

Left ventricular hypertrophy: what lies beneath?

Pol Arch Intern Med. 2019, Vol. 129, No. 12: 945-948 / DOI: 10.20452/pamw.15118

A challenging phenotype of pulmonary arterial hypertension

Kamil Jonas, Grzegorz Kopeć

Pol Arch Intern Med. 2020, Vol. 130, No. 1: 85-86 / DOI: 10.20452/pamw.15103

Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists. Authors' reply

Pol Arch Intern Med. 2019, Vol. 129, No. 9: 649-650 / DOI: 10.20452/pamw.14999

Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists

Pol Arch Intern Med. 2019, Vol. 129, No. 9: 648-649 / DOI: 10.20452/pamw.14998

End-of-life care for patients with advanced lung cancer and chronic obstructive pulmonary disease. Authors' reply

Pol Arch Intern Med. 2019, Vol. 129, No. 6: 436-437 / DOI: 10.20452/pamw.14886

End-of-life care for patients with advanced lung cancer and chronic obstructive pulmonary disease

Pol Arch Intern Med. 2019, Vol. 129, No. 6: 436-436 / DOI: 10.20452/pamw.14885

Iron deficiency in patients with chronic kidney disease requiring hemodialysis: do inflammation and overexpressed hepcidin contribute significantly? Authors' reply

Jolanta Małyszko, Ewa Koc-Żórawska, Nomy Levin‑Iaina, Jacek Małyszko, Piotr Koźmiński, Grażyna Kobus, Michał Myśliwiec

Pol Arch Intern Med. 2013, Vol. 123, No. 1-2: 68-70 / DOI: 10.20452/pamw.14790

Time to rethink the role of sodium-glucose co-transporter 2 inhibitors in the elderly. Authors' reply

Ricardo Gómez-Huelgas, Luis M. Pérez‑Belmonte, Almudena López‑Sampalo, Juan C. Morilla‑Herrera, José M. Bellosta‑Ymbert, M. Rosa Bernal‑López

Pol Arch Intern Med. 2019, Vol. 129, No. 2: 143-144 / DOI: 10.20452/pamw.4470

Time to rethink the role of sodium-glucose co-transporter 2 inhibitors in the elderly

Dimitrios Patoulias, Konstantinos Stavropoulos, Konstantinos Imprialos, Michael Doumas

Pol Arch Intern Med. 2019, Vol. 129, No. 2: 143-144 / DOI: 10.20452/pamw.4469

World Thrombosis Day 2018 in Poland

Krystyna Zawilska, Jerzy Windyga

Pol Arch Intern Med. 2019, Vol. 129, No. 1: 69-71 / DOI: 10.20452/pamw.4432

Comment on “Renal abscess complicated by duodenal obstruction in a patient with obesity and type 2 diabetes mellitus treated with gliflozin”. Authors' reply

Wojciech Gierlikowski, Grzegorz Rosiak, Katarzyna Trautsolt-Jeziorska, Marek Rosłon, Tomasz Bednarczuk

Pol Arch Intern Med. 2018, Vol. 128, No. 10: 634-635 / DOI: 10.20452/pamw.4361

Comment on “Renal abscess complicated by duodenal obstruction in a patient with obesity and type 2 diabetes mellitus treated with gliflozin”

Dimitrios Patoulias, Theodoros Michailidis, Petros Keryttopoulos

Pol Arch Intern Med. 2018, Vol. 128, No. 10: 634-635 / DOI: 10.20452/pamw.4360

Dislocation of a metal stent to the lumen of a large infected pseudocyst: questions addressing the next steps in management. Authors' reply

Łukasz Krupa, Robert Staroń, Mariusz Partyka, Krzysztof Gutkowski

Pol Arch Intern Med. 2018, Vol. 128, No. 10: 631-633 / DOI: 10.20452/pamw.4359

Dislocation of a metal stent to the lumen of a large infected pseudocyst: questions addressing the next steps in management

Mateusz Jagielski, Marek Jackowski

Pol Arch Intern Med. 2018, Vol. 128, No. 10: 631-633 / DOI: 10.20452/pamw.4358

Fabry disease in Poland

Stanisława Bazan-Socha, Paweł Kuczia, Jacek Musiał, Beata Błażejewska-Hyżorek

Pol Arch Intern Med. 2018, Vol. 128, No. 9: 567-568 / DOI: 10.20452/pamw.4342

Safe administration of rituximab in patients with chronic lymphocytic leukemia and a history of obinutuzumab‑associated anaphylaxis

Aleksander Salomon‑Perzyński, Agnieszka Końska, Daria Zawirska, Ewa Lech‑Marańda, Krzysztof Jamroziak

Pol Arch Intern Med. 2018, Vol. 128, No. 7-8: 494-495 / DOI: 10.20452/pamw.4327

Interleukin 27 in bronchoalveolar lavage fluid in patients with non–small cell lung cancer. Authors' reply.

Piotr Kopiński, Tomasz Wandtke, Ewelina Wędrowska, Joanna Chorostowska‑Wynimko

Pol Arch Intern Med. 2018, Vol. 128, No. 4: 266-268 / DOI: 10.20452/pamw.4258

Interleukin 27 in bronchoalveolar lavage fluid in patients with non–small cell lung cancer

Tomohiro Tamura, Toshihiro Shiozawa, Hideyasu Yamada, Kunihiko Miyazaki, Hiroaki Satoh

Pol Arch Intern Med. 2018, Vol. 128, No. 4: 266-266 / DOI: 10.20452/pamw.4257

previousof 11next

Impact Factor 2022

4.8

IC value for 2022

217.18

Ministry of Education and Science score

200
Average times from:
submission to 1st decision, 2 days
submission to first reviews, 24 days
acceptance to online first publication, 5 days
acceptance to final publication, 45 days

Current manuscript acceptance rate: 27%
The journal is co-financed from the state budget under the "Development of scientific journals" program of the Ministry of Education and Science in the years 2022-2024. Read more